The Jeffrey M. Carlton Heart and Vascular Institute at Hoag is committed to supporting clinical research that complements our patient care initiatives.
Clinical Research at the Jeffrey M. Carlton Heart and Vascular Institute is supported by Hoag’s Center for Research & Education (HCRE) and includes various industry-sponsored studies, which include both drug and medical devices. Major areas of focus include cardiac imaging studies, techniques for testing and programming implantable cardiac defibrillators/pacemakers and cardiac valve surgery.
Available Cardiovascular Clinical Trials:
(154-17) Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease (Appropriate for patients with thoracic aortic disease.)
(169-19) The Society for Vascular Surgery Patient Safety Organization (SVS PSO) TransCarotid Artery Revascularization (TCAR) Surveillance Project
(170-19) Implantable Cardioverter Defibrillator (ICD Registry) (Clinical research study, appropriate for patients with heart failure, nonischemic or ischemic cardiomyopathy, ventricular arrhythmia, or cardiac device complications.)
(235-21) CONVERGE Post-Approval Study (PAS)
(130-24) EndurAnt Stent Graft system vs ExcluDer endoprosthesis: a global, prospectiVe, rANdomized Clinical trial in sac rEgression (ADVANCE Trial)
To learn more about available clinical trials, please at 949-764-4577 or clinicalresearch@hoag.org.